Skip to main content
logo
Abrdn Life Sciences Investors (HQL)
NYSE: HQL · Real-Time Price · USD
19.90
+0.20 (1.02%)
At close: Aug 5, 2026, 4:00 PM EDT
19.90
0.00 (0.00%)
After-hours: Aug 5, 2026, 4:10 PM EDT

HQL Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Other Revenue
1.111.943.983.53.022.29
Revenue
1.111.943.983.53.022.29
Revenue Growth
-42.75%-51.30%13.75%15.89%32.05%-32.59%
Gross Profit
1.111.943.983.53.022.29
Selling, General & Admin
5.865.315.95.676.016.43
Operating Expenses
5.865.315.95.676.016.43
Operating Income
-4.75-3.37-1.92-2.18-2.99-4.14
Currency Exchange Gain (Loss)
-0---00-0.01
Other Non Operating Income (Expenses)
2.070.850.69-1.752.08
EBT Excluding Unusual Items
-2.68-2.52-1.23-2.18-1.24-2.06
Gain (Loss) on Sale of Investments
200.8588.1186.5324.53-103.3766.59
Pretax Income
198.1785.5985.322.35-104.664.53
Net Income
198.1785.5985.322.35-104.664.53
Net Income to Common
198.1785.5985.322.35-104.664.53
Net Income Growth
131.52%0.35%281.60%---47.56%
Shares Outstanding (Basic)
303028272625
Shares Outstanding (Diluted)
303028272625
Shares Change
2.73%5.48%4.74%4.33%4.10%3.29%
EPS (Basic)
6.522.893.040.83-4.072.62
EPS (Diluted)
6.522.893.040.83-4.072.62
EPS Growth
125.36%-4.86%264.33%---49.23%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Dividend Per Share
1.9101.8201.6601.2801.4701.670
Dividend Growth
4.95%9.64%29.69%-12.93%-11.98%13.61%
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-428.36%-174.11%-48.25%-62.18%-99.05%-181.04%
Profit Margin
17856.98%4415.74%2143.13%638.86%-3464.88%2822.50%
EBIT
-4.75-3.37-1.92-2.18-2.99-4.14
EBIT Margin
--174.11%-48.25%-62.18%-99.05%-181.04%
Revenue as Reported
1.111.943.983.53.022.29
SEC Filings: 10-K · 10-Q